Avricore Health (AVCRF) Operating Income (2009 - 2025)
Avricore Health (AVCRF) posted quarterly Operating Income of -$277279.6 for Q3 2025, down 116.15% YoY from $1.7 million in Q3 2024, and up 18.94% sequentially from -$342079.5 in Q2 2025.
Avricore Health (AVCRF) Operating Income (2009 - 2025) Analysis & Trends
Avricore Health has disclosed Operating Income across 15 years of filings, most recently posting -$277279.6 for Q3 2025.
- In Q3 2025, Operating Income fell 116.15% year-over-year to -$277279.6; the TTM figure through Sep 2025 stood at -$800532.2 (down 1109.5% YoY), while the FY2025 annual figure was -$990174.8, down 1150.89% from the prior year.
- Operating Income improved to -$277279.6 in Q3 2025, from -$342079.5 in the prior quarter.
- Over the last five years, Operating Income for AVCRF reached as high as $117610.1 in Q1 2024 and fell as low as -$342079.5 in Q2 2025.
- The 5-year median for Operating Income is -$69567.0 (2021), against an average of -$91330.5.
- Annual changes were most pronounced in 2023 — Operating Income soared 582.64% — and 2025, when it plunged 965.42%.
- A 5-year view of Operating Income shows it stood at -$85675.5 in 2021, then plunged by 105.26% to -$175856.1 in 2022, then jumped by 128.68% to $50442.8 in 2023, then sank by 354.31% to -$128280.7 in 2024, then slumped by 116.15% to -$277279.6 in 2025.
- According to Business Quant data, Operating Income over the past three periods registered -$277279.6, -$342079.5, and -$52892.5 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -47.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.86 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 1.34 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 362.59 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -93.52 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 399.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 514.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 209.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 238.95 Mn |
| 10 | Avricore Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -277,279.56 |
| Jun 30, 2025 | -342,079.46 |
| Mar 31, 2025 | -52,892.48 |
| Sep 30, 2024 | -128,280.68 |
| Jun 30, 2024 | 39,527.65 |
| Mar 31, 2024 | 117,610.10 |
| Dec 31, 2023 | 50,442.76 |
| Sep 30, 2023 | -212,217.22 |
| Jun 30, 2023 | -211,529.47 |
| Mar 31, 2023 | 71,465.76 |
| Dec 31, 2022 | -175,856.15 |
| Sep 30, 2022 | -140,716.34 |
| Jun 30, 2022 | -164,605.65 |
| Mar 31, 2022 | -14,807.40 |
| Dec 31, 2021 | -85,675.54 |
| Sep 30, 2021 | -25,635.59 |
| Jun 30, 2021 | -53,458.50 |
| Mar 31, 2021 | -37,961.89 |
| Dec 31, 2020 | -36,101.43 |
| Sep 30, 2020 | -15,758.15 |